Researchers studied the relationship between the distribution of centers that perform percutaneous microaxial VAD implantation and cardiogenic shock outcomes.
Dr. Alexandre Mebazaa is Professor of Medicine at Université Paris Cité (France), Chair of Department of Anesthesia & Critical Care and an expert in heart failure and cardiogenic shock.
Two heart pump systems were approved for the treatment of acute decompensated HF and cardiogenic shock in certain pediatric patients. Real-world data are needed to support on-label use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback